Page last updated: 2024-11-01

ofloxacin and Basedow Disease

ofloxacin has been researched along with Basedow Disease in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akamizu, T1
Kaneko, H1
Noguchi, N1
Kashii, S1
Nakao, K1

Other Studies

1 other study available for ofloxacin and Basedow Disease

ArticleYear
Moisture chamber for management of corneal ulcer due to Graves' ophthalmopathy.
    Thyroid : official journal of the American Thyroid Association, 2000, Volume: 10, Issue:12

    Topics: Corneal Ulcer; Female; Graves Disease; Humans; Humidity; Methylprednisolone; Middle Aged; Ofloxacin;

2000